Legal & General Group Plc - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$7,994,000
+68.1%
46,449
+22.6%
0.00%
+50.0%
Q2 2021$4,756,000
+0.7%
37,900
+8.8%
0.00%0.0%
Q1 2021$4,723,000
+7.9%
34,831
+1.8%
0.00%0.0%
Q4 2020$4,376,000
-3.7%
34,201
-15.3%
0.00%0.0%
Q3 2020$4,543,000
+24.6%
40,371
+5.5%
0.00%0.0%
Q2 2020$3,646,000
+45.3%
38,267
+37.0%
0.00%
+100.0%
Q1 2020$2,510,000
+80.4%
27,938
+6.4%
0.00%0.0%
Q4 2019$1,391,000
+58.1%
26,251
+17.8%
0.00%
Q3 2019$880,000
+15.8%
22,279
+20.4%
0.00%
Q2 2019$760,000
-8.0%
18,502
+4.3%
0.00%
Q1 2019$826,000
+14.2%
17,744
+6.8%
0.00%
-100.0%
Q4 2018$723,000
-6.6%
16,608
+22.8%
0.00%0.0%
Q3 2018$774,000
+17.6%
13,521
-0.3%
0.00%0.0%
Q2 2018$658,000
+16.5%
13,565
-6.2%
0.00%
Q1 2018$565,000
-21.6%
14,454
-14.8%
0.00%
-100.0%
Q4 2017$721,000
+22.6%
16,956
+6.9%
0.00%
Q3 2017$588,000
+84.9%
15,862
+51.5%
0.00%
Q2 2017$318,000
+26.2%
10,470
+9.7%
0.00%
Q1 2017$252,000
+2.0%
9,547
-1.1%
0.00%
Q4 2016$247,000
+71.5%
9,653
+144.1%
0.00%
Q3 2016$144,000
-0.7%
3,954
-6.2%
0.00%
Q2 2016$145,000
+33.0%
4,214
+4.3%
0.00%
Q1 2016$109,000
-25.9%
4,041
+33.8%
0.00%
Q4 2015$147,000
+101.4%
3,0210.0%0.00%
Q3 2015$73,000
-21.5%
3,0210.0%0.00%
Q2 2015$93,000
-21.2%
3,0210.0%0.00%
Q1 2015$118,000
+0.9%
3,0210.0%0.00%
Q4 2014$117,000
+20.6%
3,021
-7.6%
0.00%
Q3 2014$97,0003,2690.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders